Free Trial

IDEXX Laboratories (IDXX) SEC Filings & 10K Form

IDEXX Laboratories logo
$412.26 +3.23 (+0.79%)
(As of 12/20/2024 05:51 PM ET)

Recent IDEXX Laboratories SEC Filings

DateFilerForm TypeView
12/09/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
4:00 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:36 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:48 PM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
6:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:47 AM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:14 PM
IDEXX Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
12:23 PM
IDEXX Laboratories (Filer)
Form 8-K/A
10/31/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:18 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
3:20 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:36 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:20 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:03 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:00 PM
IDEXX Laboratories (Filer)
Form SD
Specialized Disclosure Report  
05/17/2024
2:49 PM
Claflin Bruce L. (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
6:00 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 PM
Britt Irene Chang (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 PM
Claflin Bruce L. (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
COLLINS Asha (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
ESSIG STUART (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
Kingsley Lawrence D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
SAMAD SAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:56 PM
IDEXX Laboratories (Subject)
POLEWACZYK JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
4:36 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
3:17 PM
IDEXX Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
4:54 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:55 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:55 PM
Hunt Nimrata (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:56 PM
IDEXX Laboratories (Issuer)
Johnson Michael Perkins (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:56 PM
IDEXX Laboratories (Issuer)
Lane Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:56 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:57 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:57 PM
IDEXX Laboratories (Issuer)
POLEWACZYK JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:58 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

02/16/2024
4:58 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:58 PM
IDEXX Laboratories (Issuer)
Underberg Sharon E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:01 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:02 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:03 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
4:26 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
6:01 PM
IDEXX Laboratories (Subject)
MAZELSKY JONATHAN JAY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
5:17 PM
IDEXX Laboratories (Subject)
MCKEON BRIAN P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
4:00 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
IDEXX Laboratories (Subject)
Form SC 13G/A
01/05/2024
4:01 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/05/2024
4:02 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IDXX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners